Sudden death characterizes the mode of demise in 30–50% of patients with chronic heart
failure and a reduced ejection fraction. Occasionally, these events have an identifiable …

Patients with cardiac diseases or conditions with high risk of developing cardiac diseases
undergo risk assessment by cardiologists, primary care physicians, and scientists based on …

Abstract Aims The EUropean Comparative Effectiveness Research to Assess the Use of
Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective …

Background Implantable cardioverter-defibrillator (ICD) therapy is recommended to reduce
mortality risk in patients with heart failure with reduced ejection fraction (HFrEF). Frailty is …

Ischaemic cardiomyopathy (ICM) represents an important cardiovascular condition
associated with substantially increased morbidity and mortality. It is characterised from a …

Cardiomyopathies are a significant contributor to cardiovascular morbidity and mortality,
mainly due to the development of heart failure and increased risk of sudden cardiac death …

Aims Current guidelines recommend implantable cardioverter‐defibrillator (ICD) therapy in
patients with heart failure, a left ventricular ejection fraction of≤ 35%, and New York Heart …

Aims Concerns about the prognostic value of NYHA functional class (FC) in heart failure
(HF) patients carrying a prophylactic implantable cardioverter defibrillator (ICD) are still …

Objective The 'surprise question'(SQ) and the palliative care screening tool (PCST) are the
common assessment tools in the early identification of patients requiring palliative care …

In a contemporary setting, where the risk of sudden cardiac death (SCD) is low, heart failure
management is improved, and technology is advanced, identifying the patients who would …